Company News

Share this article:

Cortex Pharmaceuticals, a California-based manufacturer of drug therapies for psychiatric disorders and neurological diseases, announced an organizational restructuring that includes a 50% reduction in workforce. Cortex cited the current financial climate—specifically uncertain capital markets—as the reason for workforce reductions.  

 

Eye care company Alcon launched a website—www.patanase.com—in support of its Patanase nasal spray, a prescription drug indicated for the relief of symptoms associated with seasonal allergic rhinitis in patients 12 years and older.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.

AbbVie's files all-oral HCV drug with FDA

AbbVie's all-oral HCV treatment filed off six Phase-III trials spanning 25 countries and 2,300 patients

Rumor: Pfizer offered to buy AstraZeneca

The rumored $101 billion bid would give Pfizer a foothold in imuno-oncology and diabetes.